4.1 Article

Optimizing recombinant antibodies for intracellular function using hitchhiker-mediated survival selection

期刊

PROTEIN ENGINEERING DESIGN & SELECTION
卷 27, 期 10, 页码 351-358

出版社

OXFORD UNIV PRESS
DOI: 10.1093/protein/gzu038

关键词

antigen-binding affinity; directed evolution; intracellular antibody engineering; protein folding and stability; twin-arginine translocation

资金

  1. National Science Foundation [CBET-0449080]
  2. National Cancer Institute at National Institutes of Health [CA132223A]
  3. New York State Office of Science, Technology and Academic Research Distinguished Faculty Award
  4. Thai Royal Government Fellowship
  5. National Institutes of Health Chemical Biology Interface Training Grant [T32 GM008500]
  6. National Science Foundation GK12 Fellowship

向作者/读者索取更多资源

The 'hitchhiker' mechanism of the bacterial twin-arginine translocation pathway has previously been adapted as a genetic selection for detecting pairwise protein interactions in the cytoplasm of living Escherichia coli cells. Here, we extended this method, called FLI-TRAP, for rapid isolation of intracellular antibodies (intrabodies) in the single-chain Fv format that possess superior traits simply by demanding bacterial growth on high concentrations of antibiotic. Following just a single round of survival-based enrichment using FLI-TRAP, variants of an intrabody against the dimerization domain of the yeast Gcn4p transcription factor were isolated having significantly greater intracellular stability that translated to yield enhancements of > 10-fold. Likewise, an intrabody specific for the non-amyloid component region of alpha-synuclein was isolated that has similar to 8-fold improved antigen-binding affinity. Collectively, our results illustrate the potential of the FLI-TRAP method for intracellular stabilization and affinity maturation of intrabodies, all without the need for purification or immobilization of the antigen.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据